Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04574583
Title Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

oropharynx cancer

Advanced Solid Tumor

head and neck squamous cell carcinoma

triple-receptor negative breast cancer

head and neck cancer

Therapies

FPV-CV301 + M7824 + MVA-BN-CV301 + SX-682

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST